@article{article, title  = {{Implications and benefits of the NICE appraisal of pembrolizumab}},

 publisher = {{Mark Allen Group}},

 url = {{https://doi.org/10.12968/bjhc.2015.21.11.506 }},

 year = {{2015}},

 month = {{11}},

 author = {{Danson S}},

 doi = {{10.12968/bjhc.2015.21.11.506}},

 volume = {{21}},

 journal = {{British Journal of Healthcare Management}},

 issue = {{11}},

 pages = {{506-508}},

 note = {{Accessed on 2025/12/07}}}